Medicine and Dentistry
Malignant Neoplasm
100%
Emergency Department
64%
Immune Checkpoint Inhibitor
26%
Cancer
17%
Emergency Medicine
16%
Symptomatic Treatment
15%
Oncology
14%
Cancer Therapy
13%
Diseases
13%
Chronic Kidney Disease
12%
Transplantation
11%
Nephropathy
11%
Breast Cancer
11%
Acute Kidney Injury
11%
Overall Survival
11%
Immunity
10%
Head and Neck Cancer
10%
Immune-Related Adverse Events
10%
Advanced Cancer
10%
Lung Cancer
10%
Immunotherapy
9%
Glycon
9%
Odds Ratio
8%
Neoplasm
8%
Diabetic Nephropathy
7%
Analgesia
7%
Prevalence
7%
Systematic Review
7%
Infection
7%
Triage
7%
Adverse Effect
6%
Pulmonary Embolism
6%
Hazard Ratio
6%
Kidney Graft
6%
Adverse Event
6%
Nephrology
6%
Chemoradiotherapy
5%
COVID-19
5%
Emergency Care
5%
Pancreas Cancer
5%
Esophageal Squamous Cell Carcinoma
5%
Resuscitation
5%
Metastatic Carcinoma
5%
Venous Thromboembolism
5%
Nephrotoxicity
5%
Cancer Treatment
5%
Liver Transplantation
5%
Diabetes
5%
Randomized Controlled Trial
5%
Clinical Trial
5%
Supportive Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
79%
Immune Checkpoint Inhibitor
15%
Diseases
15%
Chronic Kidney Failure
11%
Anaplastic Thyroid Carcinoma
10%
Diabetic Nephropathy
10%
Adverse Event
10%
Chemotherapy
9%
Manumycin
9%
Lung Cancer
9%
Head and Neck Cancer
8%
Acute Kidney Failure
8%
Overall Survival
8%
Paclitaxel
7%
Neoplasm
7%
Prevalence
7%
Breast Cancer
7%
Pancreas Cancer
6%
Kidney Disease
6%
Immunotherapy
6%
Febrile Neutropenia
6%
Metformin
6%
Advanced Cancer
6%
Infection
6%
Delirium
5%
Inflammation
5%
Clinical Trial
5%
Receptor
5%
Keyphrases
Cancer Patients
36%
In Cancer
24%
Emergency Department
23%
Immune Checkpoint Inhibitors
18%
Patients with Cancer
13%
Confidence Interval
10%
Cancer Treatment
9%
Podocyte
8%
Overall Survival
8%
Head-and-neck Cancer
8%
Comprehensive Cancer Center
8%
Emergency Medicine
8%
Esophageal Squamous Cell Carcinoma
7%
Metformin
7%
Anaplastic Thyroid Cancer
6%
Immune-related Adverse Events
6%
Acute Kidney Injury
6%
Oncologic Emergency
6%
Hazard Ratio
6%
Diabetic Nephropathy
6%
Chronic Kidney Disease
6%
Chemotherapy
6%
Malignancy
5%
Paclitaxel
5%
Pancreatic Cancer
5%
Kidney
5%
Risk Factors
5%
Checkpoint Inhibitors
5%
Manumycin
5%